quinabactin: an abscisic acid agonist; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16927350 |
| SCHEMBL ID | 15298954 |
| MeSH ID | M000603980 |
| Synonym |
|---|
| n-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-(p-tolyl)methanesulfonamide |
| F2385-0086 |
| A1O , |
| quinabactin |
| 4LA7 |
| SCHEMBL15298954 |
| AKOS024645290 |
| 946270-26-4 |
| '1-(4-methylphenyl)-n-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide' |
| 1-(4-methylphenyl)-n-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide |
| n-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-p-tolylmethanesulfonamide |
| bdbm313186 |
| us10167261, compound quinabactin |
| 1-(4-methylphenyl)-n-(2-oxo-1-propyl-3,4-dihydroquinolin-6-yl)methanesulfonamide |
| Q27457075 |
| CS-0104780 |
| HY-126478 |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Quinabactin treatments elicit guard cell closure, suppress water loss, and promote drought tolerance in adult Arabidopsis and soybean plants." | ( Activation of dimeric ABA receptors elicits guard cell closure, ABA-regulated gene expression, and drought tolerance. Cutler, SR; Defries, A; Endo, A; Nambara, E; Okamoto, M; Park, SY; Peterson, FC; Volkman, BF, 2013) | 1.11 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID977608 | Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB | 2013 | Proceedings of the National Academy of Sciences of the United States of America, Jul-16, Volume: 110, Issue:29 | Activation of dimeric ABA receptors elicits guard cell closure, ABA-regulated gene expression, and drought tolerance. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.01) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||